SCHEMBL3552970

SCHEMBL3552970

N#CC(=Cc1ccc(-n2cccn2)cc1)c1cc(F)ccc1F

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.43
KDM4E B2RXH2 2/20 0.43
MAPK1 P28482 1/20 0.43
KIF20A O95235 1/20 0.43
SMN1; SMN2 Q16637 3/20 0.42
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42
MAPT P10636 2/20 0.42
LMNA P02545 1/20 0.42
CLK1 P49759 1/20 0.40
DYRK1A Q13627 1/20 0.40
NOTUM Q6P988 1/20 0.40
KAT6A Q92794 1/20 0.39
TP53 P04637 1/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
HTT P42858 1/20 0.36
PPARD Q03181 2/20 0.35
GRM5 P41594 1/20 0.34
F2RL1 P55085 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3552968 1.00 ALDH1A1 (0.43) ALDH1A1KDM4EMAPK1KIF20ASMN1; SMN2
SCHEMBL3556106 0.87 ALDH1A1 (0.48) ALDH1A1KDM4EMAPK1KIF20ASMN1; SMN2
SCHEMBL3556104 0.87 ALDH1A1 (0.48) ALDH1A1KDM4EMAPK1KIF20ASMN1; SMN2
SCHEMBL3553622 0.81 KAT6A (0.39) ALDH1A1KDM4EKIF20ASMN1; SMN2NPC1
SCHEMBL3554594 0.79 NPC1 (0.46) ALDH1A1KDM4EMAPK1KIF20ASMN1; SMN2
SCHEMBL3554596 0.79 NPC1 (0.46) ALDH1A1KDM4EMAPK1KIF20ASMN1; SMN2
SCHEMBL3563599 0.77 MAPT (0.55) ALDH1A1KDM4EMAPK1SMN1; SMN2NPC1
SCHEMBL3563600 0.77 MAPT (0.55) ALDH1A1KDM4EMAPK1SMN1; SMN2NPC1
SCHEMBL3559709 0.72 ORAI1 (0.42) ALDH1A1KIF20ASMN1; SMN2NPC1RAB9A
SCHEMBL14379044 0.72 ORAI1 (0.42) ALDH1A1KIF20ASMN1; SMN2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7705029-B2 Acrylonitrile derivatives for inflammation and immune-related uses SYNTA PHARMACEUTICALS CORP. (US) 2010-04-27 US disclosed
EP-1732900-A4 ACRYLONITRILE DERIVATIVES FOR INFLAMMATION AND IMMUNE-RELATED USES SYNTA PHARMACEUTICALS CORP (US) 2007-12-12 EP disclosed
US-20070270478-A1 ACRYLONITRILE DERIVATIVES FOR INFLAMMATION AND IMMUNE-RELATED USES SYNTA PHARMACEUTICALS CORP. (US) 2007-11-22 US disclosed
US-7202232-B2 Acrylonitrile derivatives for inflammation and immune-related uses SYNTA PHARMACEUTICALS CORP. (US) 2007-04-10 US disclosed
EP-1732900-A2 ACRYLONITRILE DERIVATIVES FOR INFLAMMATION AND IMMUNE-RELATED USES Synta Pharmaceuticals Corporation (US) 2006-12-20 EP disclosed
US-20050272699-A1 Acrylonitrile derivatives for inflammation and immune-related uses SYNTA PHARMACEUTICALS CORP. 2005-12-08 US disclosed
WO-2005091752-A2 ACRYLONITRILE DERIVATIVES FOR INFLAMMATION AND IMMUNE-RELATED USES SYNTA PHARMACEUTICALS CORP. (US) 2005-10-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050272699-A1 Acrylonitrile derivatives for inflammation and immune-related uses IL1B, IL6, TLR4 ALDH1A1 472/4885KDM4E 4711/4885MAPK1 808/4885
US-20070270478-A1 ACRYLONITRILE DERIVATIVES FOR INFLAMMATION AND IMMUNE-RELATED USES IL1B, IL6, TLR4 ALDH1A1 472/4885KDM4E 4711/4885MAPK1 808/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.